New Document top_band
 
Business Standard

Biocon rises on healthy Q3 earnings

Q3 net profit up 9% year-on-year at Rs 93 crore against an average analyst expectation of Rs 86 crore due to higher sales.

Read more on:    Biocon | Pharma | Kiran Mazumdar-shaw
Related News

is trading higher by 4% to Rs 277 after reporting 9% year-on-year (yoy) rise in net profit at Rs 93 crore for the third quarter ended December 2012 (Q3) driven by period growth in different business verticals.

“Total sales of the company grew by 23% to Rs 635 crore from Rs 517 crore previous year,” Biocon said in a statement.

Analyst on an average had expected a net profit of Rs 86 crore and net sales of Rs 613 crore from the India’s largest biotechnology company by revenue.

“We have performed well across all our business verticals. We continue to gain market share for biosimilar insulins in global markets, which now accounts for a significant part of our business,” chairman and managing director said in a statement.

The company has received approval from the DCGI (Drugs Controller General of India) for our monoclonal antibody, Itolizumab, indicated for psoriasis. This is a significant milestone that enhances the value of this late-stage asset, added Kiran Mazumdar-Shaw.

The stock opened at Rs 268 and hit a high of Rs 278 on NSE. A combined 513,708 shares have already changed hands on the counter so far on both the exchanges.

 

Read more on:   
|
|

Read More

UCO Bank slips on declining net

Shares of UCO Bank has slumped after the bank posted a sharp drop in net profit for the third quarter ended December 31, 2012.

Quick Links

 

Market News

Markets slip as buying interest wanes; Sensex below 26,000

Markets extended losses on profit taking while lack of buying interest further accentuated the fall

MindTree hits new high; surges 20% post Q1 results

For FY15 company continues to maintain its guidance of doing better than its FY14 performance (15.1% YoY) and NASSCOM guidance of 13-15%

Sensex below 26,000; RIL down 1.5%

Coal India,TCS, ICICI Bank, Bajaj Auto and Hindalco among the top losers

Coal India declines over 5% in two-days

The stock dipped nearly 4% to Rs 364, extending its Friday's 2% decline on the National Stock Exchange.

PSU divestment hopefuls outperform markets

Stocks like BEML have risen as much as 300% in the past one year

Back to Top